Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452607 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
A Phase 1 study, sponsored by Sound Pharmaceuticals, Incorporated.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT01452607: Completed Phase 1 study, sponsored by Sound Pharmaceuticals, Incorporated.
NCT01452607 is a Phase 1 study that has completed, run by Sound Pharmaceuticals, Incorporated. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01452607, a Phase 1 study, has completed, sponsored by Sound Pharmaceuticals, Incorporated.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.
Primary Outcome
The primary objective of this study was to evaluate the safety and tolerability of SPI-1005 (ebselen) in healthy subjects. Incidence and severity of Adverse Events were determined in all treatment and placebo groups.
Interventions
- DRUG Placebo
- DRUG SPI-1005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2006-05 |
| Est. Completion | 2006-08 |
| Phase | Phase 1 |
What the finished NCT01452607 record still lists
NCT01452607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01452607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01452607 about?
NCT01452607 is a clinical study titled "Study to Evaluate the Safety and Pharmacokinetics of SPI-1005". A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.
What is the current status of trial NCT01452607?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2006-05. Estimated completion is 2006-08.
What interventions are being tested in trial NCT01452607?
The interventions under investigation include: Placebo (DRUG), SPI-1005 (DRUG).
Who is sponsoring clinical trial NCT01452607?
This trial is sponsored by Sound Pharmaceuticals, Incorporated, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01452607's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia